MYB oncoproteins: emerging players and potential therapeutic targets in human cancer

Y Cicirò, A Sala - Oncogenesis, 2021 - nature.com
MYB transcription factors are highly conserved from plants to vertebrates, indicating that
their functions embrace fundamental mechanisms in the biology of cells and organisms. In …

Celastrol: a spectrum of treatment opportunities in chronic diseases

R Cascão, JE Fonseca, LF Moita - Frontiers in medicine, 2017 - frontiersin.org
The identification of new bioactive compounds derived from medicinal plants with significant
therapeutic properties has attracted considerable interest in recent years. Such is the case of …

Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells

X Liu, P Zhao, X Wang, L Wang, Y Zhu, Y Song… - Journal of Experimental …, 2019 - Springer
Background Celastrol, a triterpene compound derived from the traditional Chinese medicine
Tripterygium wilfordii, has been reported to possess potential antitumor activity towards …

[HTML][HTML] Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies

C Wang, S Dai, X Zhao, Y Zhang, L Gong, K Fu… - Biomedicine & …, 2023 - Elsevier
Celastrol is a pentacyclic triterpenoid extracted from the traditional Chinese medicine
Tripterygium wilfordii Hook F., which has multiple pharmacological activities. In particular …

Gold Nanorods Exhibit Intrinsic Therapeutic Activity via Controlling N6-Methyladenosine-Based Epitranscriptomics in Acute Myeloid Leukemia

Y Du, M Han, K Cao, Q Li, J Pang, L Dou, S Liu, Z Shi… - ACS …, 2021 - ACS Publications
Reprograming the N 6-methyladenosine (m6A) landscape is a promising therapeutic
strategy against recalcitrant leukemia. In this study, we synthesized gold nanorods (GNRs) …

Pediatric low-grade gliomas: implications of the biologic era

RJ Packer, S Pfister, E Bouffet, R Avery… - Neuro …, 2017 - academic.oup.com
For the past decade, it has been recognized that pediatric low-grade gliomas (LGGs) and
glial-neuronal tumors carry distinct molecular alterations with resultant aberrant intracellular …

Transcription factor inhibition: lessons learned and emerging targets

A Chen, AN Koehler - Trends in molecular medicine, 2020 - cell.com
Transcription factors have roles at focal points in signaling pathways, controlling many
normal cellular processes, such as cell growth and proliferation, metabolism, apoptosis …

Targeting acute myeloid leukemia by drug-induced c-MYB degradation

V Walf-Vorderwülbecke, K Pearce, T Brooks, M Hubank… - Leukemia, 2018 - nature.com
Despite advances in our understanding of the molecular basis for particular subtypes of
acute myeloid leukemia (AML), effective therapy remains a challenge for many individuals …

Peptidomimetic blockade of MYB in acute myeloid leukemia

K Ramaswamy, L Forbes, G Minuesa, T Gindin… - Nature …, 2018 - nature.com
Aberrant gene expression is a hallmark of acute leukemias. MYB-driven transcriptional
coactivation with CREB-binding protein (CBP)/P300 is required for acute lymphoblastic and …

[HTML][HTML] A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia

Y Xu, JP Milazzo, TDD Somerville, Y Tarumoto… - Cancer cell, 2018 - cell.com
Targeting of general coactivators is an emerging strategy to interfere with oncogenic
transcription factors (TFs). However, coactivator perturbations often lead to pleiotropic effects …